Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
Blood|April 1, 2006
Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemiaMatthew F Rudd, Gabrielle S Sellick, Emily L Webb, et al.
Haematologica|March 4, 2008
High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapyMoez Dungarwalla, Steve O Evans, Unell Riley, et al.
Haematologica|February 16, 2005
Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemiaIlaria Del Giudice, Estella Matutes, Nnenna Osuji, et al.
British Journal of Haematology|September 26, 2015
An unusual indication for splenectomy in hairy cell leukaemia: a report of three cases with persistent splenomegaly after chemoimmunotherapyNadav Sarid, Humayun N Ahmad, Andrew Wotherspoon, et al.
The American Journal of Pathology|January 28, 2003
Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutationsAnne Tierens, Jan Delabie, Agnieszka Malecka, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
MTHFR polymorphisms and risk of chronic lymphocytic leukemiaMatthew F Rudd, Gabrielle S Sellick, Ruth Allinson, et al.
Cancer Genetics and Cytogenetics|September 24, 2004
Molecular cytogenetic study of a mantle cell lymphoma with a complex translocation involving the CCND1 (11q13) regionSonia Maravelaki, Anna Burford, Andrew Wotherspoon, et al.
Blood|November 17, 2007
Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the identification of genetic variants influencing prognosisGabrielle S Sellick, Rachel Wade, Susan Richards, et al.
British Journal of Haematology|August 30, 2002
Splenectomy in mantle cell lymphoma with leukaemia: a comparison with chronic lymphocytic leukaemiaRosa Ruchlemer, Andrew C Wotherspoon, Jeremy N Thompson, et al.
Haematologica|October 13, 2005
The efficacy of alemtuzumab for refractory chronic lymphocytic leukemia in relation to cytogenetic abnormalities of p53Nnenna C Osuji, Ilaria Del Giudice, Estella Matutes, et al.
Pageof 13